Comprehensive Viral Enrichment Enables Sensitive Respiratory Virus Genomic Identification and Analysis by Next Generation Sequencing

Total Page:16

File Type:pdf, Size:1020Kb

Comprehensive Viral Enrichment Enables Sensitive Respiratory Virus Genomic Identification and Analysis by Next Generation Sequencing Downloaded from genome.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press Method Comprehensive viral enrichment enables sensitive respiratory virus genomic identification and analysis by next generation sequencing Brigid M. O’Flaherty,1,2,6 Yan Li,1,6 Ying Tao,1 Clinton R. Paden,1,2 Krista Queen,1,2 Jing Zhang,1,3 Darrell L. Dinwiddie,4 Stephen M. Gross,5 Gary P. Schroth,5 and Suxiang Tong1 1Centers for Disease Control and Prevention, NCIRD, DVD, Atlanta, Georgia 30329, USA; 2Oak Ridge Institute for Science Education, Oak Ridge, Tennessee 37830, USA; 3IHRC Incorporated, Atlanta, Georgia 30346, USA; 4Department of Pediatrics, Clinical Translational Science Center, University of New Mexico, Albuquerque, New Mexico 87131, USA; 5Illumina, Incorporated, San Diego, California 92122, USA Next generation sequencing (NGS) technologies have revolutionized the genomics field and are becoming more common- place for identification of human infectious diseases. However, due to the low abundance of viral nucleic acids (NAs) in relation to host, viral identification using direct NGS technologies often lacks sufficient sensitivity. Here, we describe an approach based on two complementary enrichment strategies that significantly improves the sensitivity of NGS-based virus identification. To start, we developed two sets of DNA probes to enrich virus NAs associated with respiratory diseases. The first set of probes spans the genomes, allowing for identification of known viruses and full genome sequencing, while the second set targets regions conserved among viral families or genera, providing the ability to detect both known and poten- tially novel members of those virus groups. Efficiency of enrichment was assessed by NGS testing reference virus and clinical samples with known infection. We show significant improvement in viral identification using enriched NGS compared to unenriched NGS. Without enrichment, we observed an average of 0.3% targeted viral reads per sample. However, after enrichment, 50%–99% of the reads per sample were the targeted viral reads for both the reference isolates and clinical specimens using both probe sets. Importantly, dramatic improvements on genome coverage were also observed following virus-specific probe enrichment. The methods described here provide improved sensitivity for virus identification by NGS, allowing for a more comprehensive analysis of disease etiology. [Supplemental material is available for this article.] Numerous infectious diseases, including 25%–50% of acute low- been used to reduce levels of host NAs in a sample (Allander er respiratory tract illnesses, go undiagnosed (Garau and Calbo et al. 2001). Although these methods show modest levels of im- 2008). Failures in detection may result from the limited repertoire provement in detection of viral target sequence reads, they do of routine diagnostics or the inability of commonly used PCR not achieve the desired sensitivity. methods to pick up variants of known pathogens or unknown An alternative sequence-specific approach involves hybridi- and previously unrecognized pathogens. Using next generation se- zation-based sequence capture of specific NAs using 80- to 120- quencing (NGS) for viral detection and discovery provides signifi- mer DNA or RNA probes (Lovett et al. 1991; Albert et al. 2007; cant advantages to traditional viral diagnostic assays—full genome Hodges et al. 2007; Okou et al. 2007). Several groups have em- sequences may be obtained and targets are not limited by pre-ex- ployed this method for virus-specific capture and genome enrich- isting knowledge of the pathogen. However, one of the greatest ment prior to NGS (Depledge et al. 2011; Mate et al. 2015; Olp challenges to NGS as a routine, affordable, diagnostic tool is the et al. 2015). Using the SureSelectXT Target Enrichment System, relative paucity of viral nucleic acids (NAs) present in clinical Depledge et al. (2011) enriched human herpesviruses from clinical samples. samples, finding significant improvement in sequencing depth. In an effort to increase the proportion of viral sequences ob- Two studies have described the use of enrichment for characteriza- tained by NGS, several techniques for non-sequence-specific viral tion of Ebola virus and Kaposi’s sarcoma-associated herpesvirus enrichment have been implemented. Ultracentrifugation, sample using Illumina TruSeq RNA Access and Agilent SureSelectXT filtration, and viral culture have been used to enrich viral particles Target Enrichment, respectively (Mate et al. 2015; Olp et al. prior to nucleic acid extraction (Breitbart and Rohwer 2005; 2015). Collectively, these strategies result in increased target se- Duhaime and Sullivan 2012). Additionally, host genomic DNA quence reads and improved depth of coverage. depletion by DNase treatment or ribosomal RNA depletion have © 2018 O’Flaherty et al. This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication 6These authors contributed equally to this work. date (see http://genome.cshlp.org/site/misc/terms.xhtml). After six months, it Corresponding author: [email protected] is available under a Creative Commons License (Attribution-NonCommercial Article published online before print. Article, supplemental material, and publi- 4.0 International), as described at http://creativecommons.org/licenses/by- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.226316.117. nc/4.0/. 28:869–877 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/18; www.genome.org Genome Research 869 www.genome.org Downloaded from genome.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press O’Flaherty et al. Sequence-specific enrichment probes have also been used Results in the study of the human virome (Briese et al. 2015; Wylie Enrichment analysis of reference viruses with two hybridization et al. 2015). Briese and colleagues developed the Virome Capture Sequencing Platform for vertebrate viruses, where the authors de- probe sets signed ∼2 million viral enrichment probes to target all virus taxa Both sets of enriching probes provide significant improvement, in- where at least one virus was known to infect vertebrates (Briese creasing both the overall rate of virus detection and the percent tar- et al. 2015). This method resulted in a 100- to 1000-fold increase geted viral reads (PTRs) per sample by NGS. We first evaluated the in the number of targeted viral reads and reduction in host back- enrichment by virus-specific probes using representative reference ground. Similarly, Wylie et al. (2015) reported the ViroCap enrich- viruses from viral families associated with human respiratory dis- ment system, where a custom panel of 2.1 million genus- and eases (Supplemental Table S1). Prior to library preparation, we de- virus-specific probes targeted against vertebrate viruses from 34 termined the virus load (Ct) where real-time PCR assays were families allowed for viral enrichment in clinical specimen libraries. available. Viral Ct values ranged from about 21 to 33, depending In both studies, the probe design targeting known sequences was on the available reference virus NA stock, with most Ct values at limited in identification of highly divergent viruses. or around 25. For each sample, we generated two parallel libraries Here, we report an approach for target-based enrichment for from the same viral NA template using different sequencing indi- sensitive detection of a broad spectrum of respiratory viruses by ces. This allowed us to assess samples with and without enrich- NGS. We used two complementary panels of oligonucleotide ment on the same sequencing run. probes targeted against representative common respiratory viruses The virus-specific probe pool improved detection of target vi- as a proof of concept. They are (1) virus-specific probes that span rus for all of the reference virus NAs tested when compared to their the full genome of common respiratory viruses, and (2) conserved unenriched matches, except the HBoV1 virus (Fig. 1). Overall en- viral group probes that target against conserved regions from each richment with virus-specific probes results in a 7285-fold median of nine viral families or subfamilies that are associated with respi- increase in PTRs (increase ranges from 33- to 188,019-fold) ratory diseases. The virus-specific probes allow for full genome se- (Supplemental Table S2). Notably, 18 of the 26 (69%) samples im- quencing, which contributes to a more complete and confident proved to 50%–99% PTRs following enrichment: 229E, NL63, identification and characterization of target viruses. The conserved OC43, AdV E4, HPeV6, HRV B14, HPIV1, HPIV2, HPIV3, RSV A2, viral group probes enable detection of divergent viruses with the RSV B1, HMPV83, all five representative influenza A viruses, and potential to recognize novel viruses within these known viral one influenza B (B/Yamagata) virus (Fig. 1; Supplemental Table families. The combination of these two enrichment approaches S2). Three samples—AdV B11, HMPV75, and HPeV1—were en- is expected to increase the number of usable reads per sample riched to 20%–45% PTRs. The overall linear genome coverage and per sequencing run, significantly improving the sensitivity and depth of coverage was improved dramatically, as 73% of the and value of NGS for viral detection, discovery, and sequence samples generated a linear genome coverage of more than 85% characterization. (Supplemental Table S2), which provided
Recommended publications
  • Gut Microbiota Beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
    International Journal of Molecular Sciences Review Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD Mario Matijaši´c 1,* , Tomislav Meštrovi´c 2, Hana Cipˇci´cPaljetakˇ 1, Mihaela Peri´c 1, Anja Bareši´c 3 and Donatella Verbanac 4 1 Center for Translational and Clinical Research, University of Zagreb School of Medicine, 10000 Zagreb, Croatia; [email protected] (H.C.P.);ˇ [email protected] (M.P.) 2 University Centre Varaždin, University North, 42000 Varaždin, Croatia; [email protected] 3 Division of Electronics, Ruđer Boškovi´cInstitute, 10000 Zagreb, Croatia; [email protected] 4 Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia; [email protected] * Correspondence: [email protected]; Tel.: +385-01-4590-070 Received: 30 January 2020; Accepted: 7 April 2020; Published: 11 April 2020 Abstract: The human microbiota is a diverse microbial ecosystem associated with many beneficial physiological functions as well as numerous disease etiologies. Dominated by bacteria, the microbiota also includes commensal populations of fungi, viruses, archaea, and protists. Unlike bacterial microbiota, which was extensively studied in the past two decades, these non-bacterial microorganisms, their functional roles, and their interaction with one another or with host immune system have not been as widely explored. This review covers the recent findings on the non-bacterial communities of the human gastrointestinal microbiota and their involvement in health and disease, with particular focus on the pathophysiology of inflammatory bowel disease. Keywords: gut microbiota; inflammatory bowel disease (IBD); mycobiome; virome; archaeome; eukaryotic parasites 1. Introduction Trillions of microbes colonize the human body, forming the microbial community collectively referred to as the human microbiota.
    [Show full text]
  • Guide for Common Viral Diseases of Animals in Louisiana
    Sampling and Testing Guide for Common Viral Diseases of Animals in Louisiana Please click on the species of interest: Cattle Deer and Small Ruminants The Louisiana Animal Swine Disease Diagnostic Horses Laboratory Dogs A service unit of the LSU School of Veterinary Medicine Adapted from Murphy, F.A., et al, Veterinary Virology, 3rd ed. Cats Academic Press, 1999. Compiled by Rob Poston Multi-species: Rabiesvirus DCN LADDL Guide for Common Viral Diseases v. B2 1 Cattle Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 2 Deer and Small Ruminants Please click on the principle system involvement Generalized viral disease Respiratory viral disease Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 3 Swine Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 4 Horses Please click on the principle system involvement Generalized viral diseases Neurological viral diseases Respiratory viral diseases Enteric viral diseases Abortifacient/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 5 Dogs Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Back to the Beginning DCN LADDL Guide for Common Viral Diseases v.
    [Show full text]
  • Molecular Analysis of Carnivore Protoparvovirus Detected in White Blood Cells of Naturally Infected Cats
    Balboni et al. BMC Veterinary Research (2018) 14:41 DOI 10.1186/s12917-018-1356-9 RESEARCHARTICLE Open Access Molecular analysis of carnivore Protoparvovirus detected in white blood cells of naturally infected cats Andrea Balboni1, Francesca Bassi1, Stefano De Arcangeli1, Rosanna Zobba2, Carla Dedola2, Alberto Alberti2 and Mara Battilani1* Abstract Background: Cats are susceptible to feline panleukopenia virus (FPV) and canine parvovirus (CPV) variants 2a, 2b and 2c. Detection of FPV and CPV variants in apparently healthy cats and their persistence in white blood cells (WBC) and other tissues when neutralising antibodies are simultaneously present, suggest that parvovirus may persist long-term in the tissues of cats post-infection without causing clinical signs. The aim of this study was to screen a population of 54 cats from Sardinia (Italy) for the presence of both FPV and CPV DNA within buffy coat samples using polymerase chain reaction (PCR). The DNA viral load, genetic diversity, phylogeny and antibody titres against parvoviruses were investigated in the positive cats. Results: Carnivore protoparvovirus 1 DNA was detected in nine cats (16.7%). Viral DNA was reassembled to FPV in four cats and to CPV (CPV-2b and 2c) in four cats; one subject showed an unusually high genetic complexity with mixed infection involving FPV and CPV-2c. Antibodies against parvovirus were detected in all subjects which tested positive to DNA parvoviruses. Conclusions: The identification of FPV and CPV DNA in the WBC of asymptomatic cats, despite the presence of specific antibodies against parvoviruses, and the high genetic heterogeneity detected in one sample, confirmed the relevant epidemiological role of cats in parvovirus infection.
    [Show full text]
  • Survival of Human Norovirus Surrogates in Juices and Their Inactivation Using Novel Methods
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Masters Theses Graduate School 5-2011 Survival of Human Norovirus Surrogates In Juices and their Inactivation Using Novel Methods Katie Marie Horm [email protected] Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes Recommended Citation Horm, Katie Marie, "Survival of Human Norovirus Surrogates In Juices and their Inactivation Using Novel Methods. " Master's Thesis, University of Tennessee, 2011. https://trace.tennessee.edu/utk_gradthes/882 This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a thesis written by Katie Marie Horm entitled "Survival of Human Norovirus Surrogates In Juices and their Inactivation Using Novel Methods." I have examined the final electronic copy of this thesis for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Master of Science, with a major in Food Science and Technology. Doris H. D'Souza, Major Professor We have read this thesis and recommend its acceptance: Federico M. Harte, Gina M. Pighetti Accepted for the Council: Carolyn R. Hodges Vice Provost and Dean of the Graduate School (Original signatures are on file with official studentecor r ds.) Survival of Human Norovirus Surrogates In Juices and their Inactivation Using Novel Methods A Thesis Presented for the Master of Science Degree The University of Tennessee, Knoxville Katie Marie Horm May 2011 Acknowledgments I would like to think my major professor/advisor Dr.
    [Show full text]
  • Development of a Point-Of-Care Assay for HIV-1 Viral Load Using Higher Refractive Index Antibody-Coated Microbeads
    sensors Article Development of a Point-of-Care Assay for HIV-1 Viral Load Using Higher Refractive Index Antibody-Coated Microbeads Mazhar Sher 1,2, Benjamin Coleman 3, Massimo Caputi 4 and Waseem Asghar 1,2,5,* 1 Asghar-Lab, Micro and Nanotechnology in Medicine, College of Engineering and Computer Science, Boca Raton, FL 33431, USA; [email protected] 2 Department of Computer & Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431, USA 3 Department of Electrical and Computer Engineering, Rice University, 6100 Main Street, Houston, TX 77005, USA; [email protected] 4 Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA; [email protected] 5 Department of Biological Sciences (Courtesy Appointment), Florida Atlantic University, Boca Raton, FL 33431, USA * Correspondence: [email protected] Abstract: The detection of viruses using imaging techniques is challenging because of the weak scattering of light generated by the targets of sizes in the nanometer range. The system we have developed overcomes the light scattering problems by utilizing antibody-coated microbeads of higher index of refraction that can specifically bind with viruses and increase the acceptance angle. Using the new technology, we have developed a portable, cost-effective, and field-deployable platform for the rapid quantification of HIV-1 viral load for point-of-care (POC) settings. The system combines microfluidics with a wide field of view lensless imaging technology. Highly specific antibodies are Citation: Sher, M.; Coleman, B.; functionalized to a glass slide inside a microchip to capture HIV-1 virions. The captured virions Caputi, M.; Asghar, W.
    [Show full text]
  • Real-Time Quantitative PCR for the Design of Lentiviral Vector Analytical Assays
    Gene Therapy (2005) 12, S36–S50 & 2005 Nature Publishing Group All rights reserved 0969-7128/05 $30.00 www.nature.com/gt CONFERENCE PAPER Real-time quantitative PCR for the design of lentiviral vector analytical assays C Delenda1 and C Gaillard2 1Genethon, CNRS UMR 8115, 1bis rue de l’Internationale, Evry Cedex, France; and 2GenoSafe, 1 rue Pierre Fontaine, Evry Cedex, France From the recent and emerging concerns for approving context, have been included in the effort to dress an lentiviral vector-mediated gene transfer in human clinical exhaustive list. Also, great variations have been observed applications, several analytical methods have been applied from interlaboratory results, we have tempted to compare in preclinical models to address the lentiviral vector load between them the different analytical methods that have in batches, cells or tissues. This review points out the oldest been used to consider (i) the titration of lentiviral vector generation methods (blots, RT activity, standard PCR) as batches, (ii) the absence of the susceptible emerging well as a full description of the newest real-time quantitative replicative lentiviruses or (iii) the lentiviral vector biodistribu- PCR (qPCR) applications. Combinations of primer and probe tion in the organism. sequences, which have worked in the lentiviral amplification Gene Therapy (2005) 12, S36–S50. doi:10.1038/sj.gt.3302614 Keywords: real-time PCR; lentiviral vector; standardization Introduction This review points out the major progress undertaken for the standardization of some of these technical Lentiviral-derived transfer vectors have gained increased expertises. Associated with conventional detection attention because their karyophilic properties allow their methods, techniques derived from qPCR have been use for the transduction of quiescent cells.1,2 The applied in the lentiviral vector context for the evaluation acceptance of their use in clinical settings will require of titration, RCL and biodistribution in animal models.
    [Show full text]
  • Genetic Content and Evolution of Adenoviruses Andrew J
    Journal of General Virology (2003), 84, 2895–2908 DOI 10.1099/vir.0.19497-0 Review Genetic content and evolution of adenoviruses Andrew J. Davison,1 Ma´ria Benko´´ 2 and Bala´zs Harrach2 Correspondence 1MRC Virology Unit, Institute of Virology, Church Street, Glasgow G11 5JR, UK Andrew Davison 2Veterinary Medical Research Institute, Hungarian Academy of Sciences, H-1581 Budapest, [email protected] Hungary This review provides an update of the genetic content, phylogeny and evolution of the family Adenoviridae. An appraisal of the condition of adenovirus genomics highlights the need to ensure that public sequence information is interpreted accurately. To this end, all complete genome sequences available have been reannotated. Adenoviruses fall into four recognized genera, plus possibly a fifth, which have apparently evolved with their vertebrate hosts, but have also engaged in a number of interspecies transmission events. Genes inherited by all modern adenoviruses from their common ancestor are located centrally in the genome and are involved in replication and packaging of viral DNA and formation and structure of the virion. Additional niche-specific genes have accumulated in each lineage, mostly near the genome termini. Capture and duplication of genes in the setting of a ‘leader–exon structure’, which results from widespread use of splicing, appear to have been central to adenovirus evolution. The antiquity of the pre-vertebrate lineages that ultimately gave rise to the Adenoviridae is illustrated by morphological similarities between adenoviruses and bacteriophages, and by use of a protein-primed DNA replication strategy by adenoviruses, certain bacteria and bacteriophages, and linear plasmids of fungi and plants.
    [Show full text]
  • First Description of Adenovirus, Enterovirus, Rotavirus and Torque
    First description of Adenovirus, Enterovirus, Rotavirus and Torque teno virus in water samples collected from the Arroio Dilúvio, Porto Alegre, Brazil Vecchia, AD.a,b, Fleck, JD.a,b, Comerlato, J.c, Kluge, M.b, Bergamaschi, B.c, Da Silva, JVS.b, Da Luz, RB.b, Teixeira, TF.b, Garbinatto, GN.d, Oliveira, DV.d, Zanin, JG.d, Van der Sand, S.d, Frazzon, APG.d, Franco, AC.c, Roehe, PM.c,e and Spilki, FR.a,b* aPrograma de Pós-Graduação em Qualidade Ambiental, Universidade Feevale, CEP 93352-000, Novo Hamburgo, RS, Brazil bLaboratório de Microbiologia Molecular, Instituto de Ciências da Saúde, Universidade Feevale, CEP 93352-000, Novo Hamburgo, RS, Brazil cLaboratório de Virologia, Departamento de Microbiologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul – UFRGS, Av. Sarmento Leite, 500, CEP 90050-170, Porto Alegre, RS, Brazil dDepartamento de Microbiologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul – UFRGS, Av. Sarmento Leite, 500, CEP 90050-170, Porto Alegre, RS, Brazil eInstituto de Pesquisa Veterinária “Desidério Finamor” – IPVDF, Fundação Estadual de Pesquisa Agropecuária – FEPAGRO-Saúde Animal, Estrada do Conde, 6000, CEP 92990-000, Eldorado do Sul, RS, Brazil *e-mail: [email protected] Received May 11, 2011 – Accepted July 14, 2011 – Distributed May 31, 2012 (With 1 figure) Abstract Adenovirus (AdV), enterovirus (EV), genogroup A rotaviruses (GARV) and Torque teno virus (TTV) are non-enveloped viral agents excreted in feces and so may contaminate water bodies. In the present study, the molecular detection of these viruses was performed in samples of surface water collected from the Arroio Dilúvio, a waterstream that crosses the city of Porto Alegre, RS, Brazil, receiving great volumes of non-treated sewage from a large urban area.
    [Show full text]
  • ICTV Virus Taxonomy Profile: Parvoviridae
    ICTV VIRUS TAXONOMY PROFILES Cotmore et al., Journal of General Virology 2019;100:367–368 DOI 10.1099/jgv.0.001212 ICTV ICTV Virus Taxonomy Profile: Parvoviridae Susan F. Cotmore,1,* Mavis Agbandje-McKenna,2 Marta Canuti,3 John A. Chiorini,4 Anna-Maria Eis-Hubinger,5 Joseph Hughes,6 Mario Mietzsch,2 Sejal Modha,6 Mylene Ogliastro,7 Judit J. Penzes, 2 David J. Pintel,8 Jianming Qiu,9 Maria Soderlund-Venermo,10 Peter Tattersall,1,11 Peter Tijssen12 and ICTV Report Consortium Abstract Members of the family Parvoviridae are small, resilient, non-enveloped viruses with linear, single-stranded DNA genomes of 4–6 kb. Viruses in two subfamilies, the Parvovirinae and Densovirinae, are distinguished primarily by their respective ability to infect vertebrates (including humans) versus invertebrates. Being genetically limited, most parvoviruses require actively dividing host cells and are host and/or tissue specific. Some cause diseases, which range from subclinical to lethal. A few require co-infection with helper viruses from other families. This is a summary of the International Committee on Taxonomy of Viruses (ICTV) Report on the Parvoviridae, which is available at www.ictv.global/report/parvoviridae. Table 1. Characteristics of the family Parvoviridae Typical member: human parvovirus B19-J35 G1 (AY386330), species Primate erythroparvovirus 1, genus Erythroparvovirus, subfamily Parvovirinae Virion Small, non-enveloped, T=1 icosahedra, 23–28 nm in diameter Genome Linear, single-stranded DNA of 4–6 kb with short terminal hairpins Replication Rolling hairpin replication, a linear adaptation of rolling circle replication. Dynamic hairpin telomeres prime complementary strand and duplex strand-displacement synthesis; high mutation and recombination rates Translation Capped mRNAs; co-linear ORFs accessed by alternative splicing, non-consensus initiation or leaky scanning Host range Parvovirinae: mammals, birds, reptiles.
    [Show full text]
  • Protoparvovirus Knocking at the Nuclear Door
    viruses Review Protoparvovirus Knocking at the Nuclear Door Elina Mäntylä 1 ID , Michael Kann 2,3,4 and Maija Vihinen-Ranta 1,* 1 Department of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, FI-40500 Jyvaskyla, Finland; elina.h.mantyla@jyu.fi 2 Laboratoire de Microbiologie Fondamentale et Pathogénicité, University of Bordeaux, UMR 5234, F-33076 Bordeaux, France; [email protected] 3 Centre national de la recherche scientifique (CNRS), Microbiologie Fondamentale et Pathogénicité, UMR 5234, F-33076 Bordeaux, France 4 Centre Hospitalier Universitaire de Bordeaux, Service de Virologie, F-33076 Bordeaux, France * Correspondence: maija.vihinen-ranta@jyu.fi; Tel.: +358-400-248-118 Received: 5 September 2017; Accepted: 29 September 2017; Published: 2 October 2017 Abstract: Protoparvoviruses target the nucleus due to their dependence on the cellular reproduction machinery during the replication and expression of their single-stranded DNA genome. In recent years, our understanding of the multistep process of the capsid nuclear import has improved, and led to the discovery of unique viral nuclear entry strategies. Preceded by endosomal transport, endosomal escape and microtubule-mediated movement to the vicinity of the nuclear envelope, the protoparvoviruses interact with the nuclear pore complexes. The capsids are transported actively across the nuclear pore complexes using nuclear import receptors. The nuclear import is sometimes accompanied by structural changes in the nuclear envelope, and is completed by intranuclear disassembly of capsids and chromatinization of the viral genome. This review discusses the nuclear import strategies of protoparvoviruses and describes its dynamics comprising active and passive movement, and directed and diffusive motion of capsids in the molecularly crowded environment of the cell.
    [Show full text]
  • Section 2: Virology, HIV and Viral Load
    Section 2: Virology, HIV and viral load www.i-Base.info Section 2: Virology, HIV and viral load 2 2.1 Introduction to Section 2 The second section provide information about HIV as a virus. What kind of infection is HIV; what happens after you are infected and how is the virus monitored? 2.2 Aims for Section 2 After reading section 2, advocates will have a basic understanding of: • The defnition of HIV. • The difference between different causes of illness: viruses, bacteria, fungi and parasites. • Viral load in early and chronic infection and the natural history of HIV. • The impact of coinfections on viral load. • Viral load tests and their accuracy. • Viral load in relation to whether or not you are taking HIV treatment (ART). • The HIV viral life cycle. • A basic theory of resistance. • CD4 count and viral load graphs and how to superimpose them. HIV i-Base: basic training for advocates S2:18 January 2016 Section 2: Virology, HIV and viral load www.i-Base.info 2.3 Defnition of HIV HIV stands for Human Immunodefciency Virus. Human – means it is a virus that infects humans. Immunodefciency – means it reduces the immune system. Virus – means that the infection is a virus! A virus is genetic organism that can only reproduce inside cells of another living organism. Some viruses are harmless and others can cause illness. Anti-viral drugs are used to treat viral infections. Viral infections that affect people with HIV include hepatitis A, B and C, herpes 2 (HSV-1 and HSV-2), cytomegalovirus (CMV), and human papilloma virus (HPV).
    [Show full text]
  • Viral Vectors for COVID-19 Vaccine Development
    viruses Review Viral Vectors for COVID-19 Vaccine Development Kenneth Lundstrom PanTherapeutics, CH1095 Lutry, Switzerland; [email protected] Abstract: Vaccine development against SARS-CoV-2 has been fierce due to the devastating COVID- 19 pandemic and has included all potential approaches for providing the global community with safe and efficient vaccine candidates in the shortest possible timeframe. Viral vectors have played a central role especially using adenovirus-based vectors. Additionally, other viral vectors based on vaccinia viruses, measles viruses, rhabdoviruses, influenza viruses and lentiviruses have been subjected to vaccine development. Self-amplifying RNA virus vectors have been utilized for lipid nanoparticle-based delivery of RNA as COVID-19 vaccines. Several adenovirus-based vaccine candidates have elicited strong immune responses in immunized animals and protection against challenges in mice and primates has been achieved. Moreover, adenovirus-based vaccine candidates have been subjected to phase I to III clinical trials. Recently, the simian adenovirus-based ChAdOx1 vector expressing the SARS-CoV-2 S spike protein was approved for use in humans in the UK. Keywords: SARS-CoV-2; COVID-19; vaccines; adenovirus; preclinical immunization; clinical trials; approved vaccine 1. Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly around the world, causing the COVID-19 pandemic, which has seen more than 100 million infections, 2.15 million deaths and a severely damaged global economy [1]. The severity Citation: Lundstrom, K. Viral and spread of COVID-19 were unprecedented compared to previous coronavirus outbreaks Vectors for COVID-19 Vaccine for SARS-CoV in 2004–2005 [2] and Middle East Respiratory Coronavirus (MERS-CoV) Development.
    [Show full text]